D. Bregman

发表

UV-induced inhibition of transcription involves repression of transcription initiation and phosphorylation of RNA polymerase II.

M. Barton, L. Mullenders, H. Vrieling, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Ultraviolet radiation alters the phosphorylation of RNA polymerase II large subunit and accelerates its proteasome-dependent degradation.

J. Zheng, D. Bregman, Z. Luo, 2001, Mutation research.

Limb-girdle Muscular Dystrophy (LGMD-1C) Mutants of Caveolin-3 Undergo Ubiquitination and Proteasomal Degradation

M. Lisanti, C. Minetti, F. Galbiati, 2000, The Journal of Biological Chemistry.

Transcription-dependent redistribution of the large subunit of RNA polymerase II to discrete nuclear domains

D. Bregman, S. van der Zee, L. Du, 1995, The Journal of cell biology.

Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia

D. Bregman, L. Goodnough, 2014, Therapeutic advances in hematology.

Splicing Factors Associate with Hyperphosphorylated RNA Polymerase II in the Absence of Pre-mRNA

D. Bregman, Euikyung Kim, L. Du, 1997, The Journal of cell biology.

The Inhibitor of Cyclin-Dependent Kinase 4a/Alternative Reading Frame (INK4a/ARF) Locus Encoded Proteins p16INK4a and p19ARF Repress Cyclin D1 Transcription through Distinct cis Elements

C. Albanese, Mahadev Rao, R. Pestell, 2004, Cancer Research.

RNA polymerase II large subunit is cleaved by caspases during DNA damage-induced apoptosis.

D. Bregman, Yi Lu, Z. Luo, 2002, Biochemical and biophysical research communications.

Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study.

D. Bregman, C. Charytan, M. Bernardo, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Efficacy of cholesterol uptake inhibition added to statin therapy among subjects following a low-carbohydrate diet: a randomized controlled trial.

D. Bregman, N. Iqbal, J. Chirinos, 2010, American Heart Journal.

Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women

M. Wolf, D. Bregman, Todd A. Koch, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Cytostellin distributes to nuclear regions enriched with splicing factors.

Y. Li, D. Bregman, L. Du, 1994, Journal of cell science.

Hyperphosphorylation of RNA Polymerase II and Reduced Neuronal RNA Levels Precede Neurofibrillary Tangles in Alzheimer Disease

I. Vincent, J. Leverenz, D. Bregman, 2001, Journal of neuropathology and experimental neurology.

Ultraviolet Radiation-induced Ubiquitination and Proteasomal Degradation of the Large Subunit of RNA Polymerase II

J. Corden, D. Bregman, S. L. Warren, 1998, The Journal of Biological Chemistry.

Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia

D. Bregman, L. Goodnough, Todd A. Koch, 2013, American journal of hematology.

Comparative Review of the Safety and Efficacy of Ferric Carboxymaltose Versus Standard Medical Care for the Treatment of Iron Deficiency Anemia in Bariatric and Gastric Surgery Patients

D. Bregman, M. Malone, C. Barish, 2013, Obesity Surgery.

Oxaliplatin: A Review of Evolving Concepts

S. Chaney, S. Mani, D. Bregman, 2002, Cancer investigation.

Molecular characterization of bovine brain P75, a high affinity binding protein for the regulatory subunit of cAMP-dependent protein kinase II beta.

D. Bregman, C. Rubin, A. Hirsch, 1991, The Journal of biological chemistry.

Intranasal ketorolac tromethamine (SPRIX®) containing 6% of lidocaine (ROX-828) for acute treatment of migraine: Safety and efficacy data from a phase II clinical trial

M. Färkkilä, D. Bregman, V. Pfaffenrath, 2012, Cephalalgia.

Structure and expression of murine malic enzyme mRNA. Differentiation-dependent accumulation of two forms of malic enzyme mRNA in 3T3-L1 cells.

H. Sul, D. Bregman, C. Rubin, 1987, The Journal of biological chemistry.

Regulation and Structure of Murine Malic Enzyme mRNA a

H. Sul, D. Bregman, C. Rubin, 1986, Annals of the New York Academy of Sciences.

Disruption of the Cockayne Syndrome B Gene Impairs Spontaneous Tumorigenesis in Cancer-Predisposed Ink4a/ARF Knockout Mice

L. Chin, N. Schreiber-Agus, R. Russell, 2001, Molecular and Cellular Biology.

Cell cycle regulation and RNA polymerase II.

R. Pestell, D. Bregman, V. Kidd, 2000, Frontiers in bioscience : a journal and virtual library.

Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette.

M. Wilson, P. Iyengar, M. Lisanti, 2000, Molecular endocrinology.

UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells.

R. Halaban, E. Friedberg, D. Bregman, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Cytostellin: A Nuclear Protein that Redistributes to Peripheral Cytoskeletal Locations During Mitosis and G1

D. Bregman, L. Du, S. L. Warren, 1994 .

Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial.

C. Adler, R. Allen, C. Earley, 2011, Sleep medicine.

Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.

R. Harrington, J. Onken, D. Bregman, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia

I. Hussain, D. Bregman, Todd A. Koch, 2013, Anemia.

The Cockayne syndrome group B DNA repair protein as an anti-cancer target.

S. Agrawal, D. Bregman, J. States, 2001, International journal of oncology.

Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design.

M. Wolf, L. Szczech, R. Harrington, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial

J. McGill, B. Bode, D. Bregman, 2015, Diabetes Care.

Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials

D. Bregman, C. Barish, Todd A. Koch, 2012, Anemia.

Yeast Carboxyl-terminal Domain Kinase I Positively and Negatively Regulates RNA Polymerase II Carboxyl-terminal Domain Phosphorylation*

J. Corden, D. Bregman, N. Conrad, 1999, Journal of Biological Chemistry.

A multicenter, randomized, active‐controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia

R. Harrington, J. Onken, D. Bregman, 2013, Transfusion.

Novel combinations with oxaliplatin.

S. Mani, D. Bregman, J. Manalo, 2000, Oncology.

High affinity binding protein for the regulatory subunit of cAMP-dependent protein kinase II-B. Cloning, characterization, and expression of cDNAs for rat brain P150.

D. Bregman, C. Rubin, N. Bhattacharyya, 1989, The Journal of biological chemistry.

Limb-girdle Muscular Dystrophy (LGMD-1C) Mutants of Caveolin-3 Undergo Ubiquitination and Proteasomal Degradation TREATMENT WITH PROTEASOMAL INHIBITORS BLOCKS THE DOMINANT NEGATIVE EFFECT OF LGMD-1C MUTANTS AND RESCUES WILD-TYPE CAVEOLIN-3*

M. Lisanti, C. Minetti, D. Bregman, 2000 .

Hepcidin Levels Predict Non-Responsiveness to Oral Iron Therapy in Patients with Iron Deficiency Anemia

D. Bregman, L. Goodnough, Todd A. Koch, 2012 .

Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study.

R. Testa, C. Sirolla, M. Boemi, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Intranasal ketorolac tromethamine (SPRIX®) containing 6% of lidocaine (ROX-828) for acute treatment of migraine: Safety and efficacy data from a phase II clinical trial

M. Färkkilä, D. Bregman, V. Pfaffenrath, 2012, Cephalalgia : an international journal of headache.